← back to search

Boris Schmidt

Agaplesion Bethanien Krankenhaus · DE
Area of research
Molecular Biology · Physiology
Research interest
Research interests include Alzheimer's disease research and treatments, Crystal structures of chemical compounds, Computational Drug Discovery Methods, and Ubiquitin and proteasome pathways.
h-index
40
citations
5,235
works
230
NIH funding
primary concept
email

Recent publications

Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells
Biomedicine & Pharmacotherapy 2023cited by 5position: middledoi
Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells.
2023cited by 5position: contributordoi
Sachkunde Interventionelle Echokardiographie
Die Kardiologie 2022cited by 4position: middledoi
Illuminating a Dark Kinase: Structure-Guided Design, Synthesis, and Evaluation of a Potent Nek1 Inhibitor and Its Effects on the Embryonic Zebrafish Pronephros.
2022cited by 3position: contributordoi
Design, synthesis and biological evaluation of novel aminopyrazole- and 7-azaindole-based Nek1 inhibitors and their effects on zebrafish kidney development.
2021cited by 3position: contributordoi
Memory trace interference impairs recall in a mouse model of Alzheimer's disease.
2020cited by 65position: contributordoi
Mutation-specific dual potentiators maximize rescue of CFTR gating mutants.
2020cited by 31position: contributordoi
Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring Mutations.
2019cited by 33position: contributordoi
Cell-Based Optimization of Covalent Reversible Ketoamide Inhibitors Bridging the Unprimed to the Primed Site of the Proteasome β5 Subunit.
2019cited by 9position: contributordoi
Evaluation of the methoxy-X04 derivative BSC4090 for diagnosis of prodromal and early Alzheimer's disease from bioptic olfactory mucosa.
2019cited by 4position: contributordoi
Discovery and validation of 2-styryl substituted benzoxazin-4-ones as a novel scaffold for rhomboid protease inhibitors
Bioorganic & Medicinal Chemistry Letters 2018cited by 22position: middledoi
Discovery and Biological Evaluation of Potent and Selective <i>N</i>-Methylene Saccharin-Derived Inhibitors for Rhomboid Intramembrane Proteases
Biochemistry 2017cited by 17position: middledoi
Matrix Metalloproteinase-8 Promotes Vascular Smooth Muscle Cell Proliferation and Neointima Formation
Arteriosclerosis Thrombosis and Vascular Biology 2013cited by 84position: middledoi
Soluble CD23 Controls IgE Synthesis and Homeostasis in Human B Cells
The Journal of Immunology 2012cited by 75position: middledoi
Functional Role of Matrix Metalloproteinase-8 in Stem/Progenitor Cell Migration and Their Recruitment Into Atherosclerotic Lesions
Circulation Research 2012cited by 49position: middledoi
Identification of Glycogen Synthase Kinase-3 Inhibitors with a Selective Sting for Glycogen Synthase Kinase-3α
Journal of Medicinal Chemistry 2012cited by 44position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2019–2023) · 2 papers (2017–2018)Feng Zhang · Affiliated Hospital of North Sichuan Medical College2 papers (2012–2013)Zhongyi Zhang · Macau University of Science and Technology2 papers (2012–2013) · 2 papers (2017–2018) · 2 papers (2017–2018)Manuel Mayr · Imperial College London2 papers (2012–2013)Claus U. Pietrzik · Johannes Gutenberg University Mainz2 papers (2017–2018) · 2 papers (2017–2018) · 2 papers (2017–2018)Qingbo Xu · Southwest Medical University2 papers (2012–2013)David C. Mikles · University of Miami2 papers (2017–2018)Dirk Schadendorf · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori2 papers (2023–2023) · 2 papers (2017–2018)Shu Ye · University of Leicester2 papers (2012–2013)Isabella Ogorek · Johannes Gutenberg University Mainz2 papers (2017–2018)Xiaoke Yin · British Heart Foundation2 papers (2012–2013)Qingzhong Xiao · Queen Mary University of London2 papers (2012–2013)Binia Drung · Technical University of Darmstadt2 papers (2012–2013) · 1 papers (2023–2023)